Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Obstetrics and Gynecology

Should Ashkenazi Jews Get Gaucher Carrier Screening?

At a Glance

Yes, medical experts highly recommend that individuals of Ashkenazi Jewish descent get carrier screening for Gaucher disease, especially before or during pregnancy. Because 1 in 10 to 15 people in this population are carriers, testing provides essential information for family planning.

Yes, if you are of Ashkenazi Jewish descent, medical experts highly recommend that you get carrier screening for Gaucher disease, especially if you are pregnant or planning to start a family. Even if you feel completely healthy and have no symptoms, you could still be a “carrier” of the gene mutation that causes the condition. Testing provides essential information that can help you and your partner make informed decisions about your family’s future.

While Gaucher disease can affect anyone, it is significantly more common in individuals of Ashkenazi Jewish descent [1][2]. Within this community, the chance of being a carrier is high—estimated to be between 1 in 10 and 1 in 15 individuals [1][3]. Modern medical guidelines increasingly recommend offering expanded “pan-ethnic” carrier screening to all individuals considering pregnancy, but targeted screening for Gaucher disease remains especially crucial for the Ashkenazi Jewish population due to this elevated frequency [4].

How is the Testing Done?

Carrier screening is straightforward and typically involves a simple blood draw or a saliva sample, which your OBGYN or primary care doctor can order [5][6]. If you are already pregnant, your doctor may recommend “concurrent testing”—where both you and your partner are tested at the same time rather than waiting for your results first. This ensures you have all the necessary information as quickly as possible.

What Does It Mean to Be a Carrier?

Being a carrier does not mean you have Gaucher disease. Gaucher disease is an autosomal recessive condition, meaning a person must inherit two mutated copies of the GBA1 gene (one from each parent) to actually develop the disease [7][8].

As a carrier, you only have one mutated copy of the gene [9]. Because you still have one normal, fully functioning copy, your body typically makes enough of the necessary enzymes to keep you completely healthy, and you will not develop the classic symptoms of Gaucher disease [9][8].

How Does This Affect Family Planning?

The primary reason to get screened is to understand the risk of passing the disease to your children. The risk depends entirely on the genetic status of both you and your reproductive partner:

  • If only one parent is a carrier: Your child cannot inherit Gaucher disease. However, there is a 50% chance they will also be a healthy carrier.
  • If both parents are carriers: There is a 25% chance with each pregnancy that your child will be born with Gaucher disease [10][4]. There is a 50% chance they will be a carrier, and a 25% chance they will not carry the mutation at all [10][4].

If both you and your partner are found to be carriers, a genetic counselor can help you explore your reproductive options. These often include in vitro fertilization (IVF) with preimplantation genetic testing (PGT-M) to select embryos without the disease, or prenatal diagnostic testing during pregnancy, such as chorionic villus sampling (CVS) or amniocentesis [4][11].

Are There Any Health Risks for Carriers?

While carriers do not develop Gaucher disease, recent research has uncovered one important health nuance. Carrying a single mutation in the GBA1 gene is linked to an increased lifetime risk of developing Parkinson’s disease compared to the general population [8][12].

This does not mean you will definitely develop Parkinson’s—most carriers do not—but it is a recognized risk factor [13]. There is no immediate action required, but you should ensure this information is noted in your permanent medical records and shared with your primary care doctor so they can monitor your neurological health as you age.

Common questions in this guide

Are Bisphosphonates Safe for Gaucher Disease Bone Loss?Do ERT or SRT Treat Gaucher Neurological Symptoms?Does Gaucher Disease Cause Growth Delays?Can Treatment Reverse Bone Damage in Gaucher Disease?How Is a Gaucher Disease Bone Crisis Treated in the ER?Will My Child Inherit Gaucher Disease?Do You Need a Bone Marrow Biopsy for Gaucher Disease?Is Gaucher Disease Treatment Safe During Pregnancy?Is There a Cure or Gene Therapy for Gaucher Disease?Should Children With Gaucher Disease Avoid Contact Sports?Gaucher Disease: Do I Need Multiple Myeloma Screening?What Is Oculomotor Apraxia in Type 3 Gaucher Disease?What Is the Parkinson's Risk With Gaucher Disease?What Blood Tests Are Used to Monitor Gaucher Disease?Why is a CYP2D6 Test Needed for Gaucher Disease SRT?
What does it mean to be a carrier of Gaucher disease?
Being a carrier means you have one mutated copy of the GBA1 gene but still have one normal copy. Because of this, you will stay completely healthy and will not develop Gaucher disease symptoms, but you could pass the gene mutation to your children.
What happens if both my partner and I are carriers for Gaucher disease?
If both parents are carriers, there is a 25% chance with each pregnancy that the child will be born with Gaucher disease. There is also a 50% chance the child will be a healthy carrier, and a 25% chance they will not carry the mutation at all.
How is the carrier testing for Gaucher disease performed?
Carrier screening is a simple and straightforward process. It typically requires just a blood draw or a saliva sample, which your primary care doctor or OBGYN can order for you in their office.
Are there any health risks for healthy Gaucher disease carriers?
While carriers do not develop Gaucher disease, having a single mutation in the GBA1 gene is linked to an increased lifetime risk of developing Parkinson's disease. Most carriers do not develop Parkinson's, but it is a recognized risk factor you should share with your doctor.
What should I do if my partner and I both test positive as carriers?
A genetic counselor can help you and your partner explore various reproductive options if you are both carriers. These options often include in vitro fertilization (IVF) with preimplantation genetic testing, or prenatal diagnostic testing during pregnancy.

Questions for Your Doctor

4 questions

  • Do you recommend a targeted Ashkenazi Jewish genetic screening panel, or a broader expanded carrier screening panel?
  • Can you facilitate concurrent testing so my partner and I can get our screening results at the same time?
  • If I test positive as a carrier, can you refer me to a genetic counselor to help me understand the specific mutation and my reproductive options?
  • How should I document the slightly increased risk of Parkinson's disease in my long-term medical records so my future doctors are aware?

Questions for You

4 questions

  • Is my partner also of Ashkenazi Jewish descent, or from another population with specific genetic risks?
  • Has anyone in my biological family ever been diagnosed with Gaucher disease, Parkinson's disease, or any other genetic condition?
  • If my partner and I are both carriers, would we prefer to explore options like IVF with genetic testing before pregnancy, or pursue prenatal testing during a pregnancy?
  • Am I emotionally prepared to receive news that I am a carrier, and how might that change my family planning timeline?

References

References (13)
  1. 1

    Population-based cohort of 500 patients with Gaucher disease in Israel.

    Jaffe DH, Flaks-Manov N, Benis A, et al.

    BMJ open 2019; (9(1)):e024251 doi:10.1136/bmjopen-2018-024251.

    PMID: 30670517
  2. 2

    Diet, β-glucocerebrosidase deficiency, and Parkinson's disease.

    Shayman JA

    Journal of lipid research 2024; (65(12)):100689 doi:10.1016/j.jlr.2024.100689.

    PMID: 39490443
  3. 3

    Recent advances in the diagnosis and management of Gaucher disease.

    Gary SE, Ryan E, Steward AM, Sidransky E

    Expert review of endocrinology & metabolism 2018; (13(2)):107-118 doi:10.1080/17446651.2018.1445524.

    PMID: 30058864
  4. 4

    Acid β-glucosidase (GBA1) gene mutational spectrum and clinical phenotypes in patients with gaucher disease: seven novel mutations in a multicenter retrospective cohort study from upper Egypt.

    Youssef MAM, Elsayed SM, Elsayh KI, et al.

    Molecular and cellular pediatrics 2025; (12(1)):14 doi:10.1186/s40348-025-00200-5.

    PMID: 41032223
  5. 5

    Prenatal diagnosis of Gaucher disease using next-generation sequencing.

    Yoshida S, Kido J, Matsumoto S, et al.

    Pediatrics international : official journal of the Japan Pediatric Society 2016; (58(9)):946-9 doi:10.1111/ped.13069.

    PMID: 27682613
  6. 6

    A new multiplex analysis of glucosylsphingosine and globotriaosylsphingosine in dried blood spots by tandem mass spectrometry.

    Van Baelen A, Roosens L, Devos S, et al.

    Molecular genetics and metabolism reports 2023; (37()):100993 doi:10.1016/j.ymgmr.2023.100993.

    PMID: 37649874
  7. 7

    Gaucher Disease: Clinical, Biological and Therapeutic Aspects.

    Dandana A, Ben Khelifa S, Chahed H, et al.

    Pathobiology : journal of immunopathology, molecular and cellular biology 2016; (83(1)):13-23 doi:10.1159/000440865.

    PMID: 26588331
  8. 8

    Evaluation of Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons from Siblings with Gaucher Disease Discordant for Parkinsonism.

    Hertz E, Rytel K, Perez G, et al.

    Movement disorders : official journal of the Movement Disorder Society 2025; (40(8)):1719-1724 doi:10.1002/mds.30273.

    PMID: 40568761
  9. 9

    Parkinsonisms and Glucocerebrosidase Deficiency: A Comprehensive Review for Molecular and Cellular Mechanism of Glucocerebrosidase Deficiency.

    Gatto EM, Da Prat G, Etcheverry JL, et al.

    Brain sciences 2019; (9(2)) doi:10.3390/brainsci9020030.

    PMID: 30717266
  10. 10

    Perinatal lethal form Gaucher disease with compound heterozygosity of single nucleotide variants and copy number variations presenting as nonimmune hydrops fetalis and cerebellar hypoplasia: A case report.

    Hsu CC, Lee NC, Chien YH, et al.

    Taiwanese journal of obstetrics & gynecology 2024; (63(5)):771-776 doi:10.1016/j.tjog.2024.03.022.

    PMID: 39266164
  11. 11

    Diagnosis and genetic analysis of Gaucher disease in a pediatric case: a case report.

    Ma M, Wu N, Feng J, et al.

    Frontiers in pediatrics 2025; (13()):1628525 doi:10.3389/fped.2025.1628525.

    PMID: 40791806
  12. 12

    GBA1-associated parkinsonism: new insights and therapeutic opportunities.

    Ryan E, Seehra G, Sharma P, Sidransky E

    Current opinion in neurology 2019; (32(4)):589-596 doi:10.1097/WCO.0000000000000715.

    PMID: 31188151
  13. 13

    Knowledge and attitudes of Parkinson's disease risk in the Gaucher population.

    Zaretsky L, Zeid N, Naik H, et al.

    Journal of genetic counseling 2020; (29(1)):105-111 doi:10.1002/jgc4.1185.

    PMID: 31663662

This information about Gaucher disease carrier screening is for educational purposes only and does not replace professional medical advice. Always discuss genetic testing and family planning options with your doctor or a certified genetic counselor.

Get notified when new evidence is published on Gaucher Disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.